Phase 1/2 clinical study of irinotecan and oral S-1 (IRIS) in patients with advanced gastric cancer

Verfasser / Beitragende:
[Yoshito Komatsu, Satoshi Yuki, Nozomu Fuse, Takashi Kato, Takuto Miyagishima, Mineo Kudo, Yasuyuki Kunieda, Miki Tateyama, Osamu Wakahama, Takashi Meguro, Yuh Sakata, Masahiro Asaka]
Ort, Verlag, Jahr:
2010
Enthalten in:
Advances in Therapy, 27/7(2010-07-01), 483-492
Format:
Artikel (online)
ID: 445091711